Table 3.
Studies | Inclusion Criteria | Random Allocation | Concealed Allocation | Groups Similar at Baseline | Blinded Participants |
Blinded Therapist | Blinded Investigators |
Data from >85% of Participants | Intention to Treat | Between Group Comparison |
Estimation of Effect and Variability |
TOTAL |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Ballesta-Garcia, 2019 [11] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Ballesta-Garcia, 2020 [12] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Blackwell et al., 2017 [20] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 |
Connolly et al., 2020 [18] | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 6 |
Engel et al., 2019 [22] |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Evangelista et al., 2019 [23] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Evangelista et al., 2021 [24] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 5 |
Islam et al., 2019 [25] |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Jimenez-Garcia et al., 2019 [21] | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |
Lu et al., 2021 [26] |
0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
McRae et al., 2012 [16] |
0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 4 |
Menz et al., 2019 [27] |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 5 |
Micielska et al., 2019 [28] | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
Murawska-Cialowicz et al., 2020 [29] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Schaun et al., 2018 [13] |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Schaun et al., 2019 [14] |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Schmidt et al., 2016 [30] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Sperlich et al., 2018 [31] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Wilke et al., 2019 [17] |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Batrakoulis et al., 2018 [32] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Jung et al., 2019 [33] |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Scott et al., 2019 [34] |
1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |